Blue Trust’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Blue Trust's DNA Position: Q3 2026 in Review
Blue Trust opened a new position in Ginkgo Bioworks (DNA) in Q3 2026: 2 shares worth $28. The stake represents ﹤0.01% of the portfolio and ranks #2490 among its holdings. This is a return to the name: Blue Trust previously reported a position in DNA as recently as Q3 2024.
Blue Trust first reported a position in DNA in Q4 2022 and has held it in 6 quarters since. The position peaked at $7K in Q4 2023. 132 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Blue Trust held 2 shares of Ginkgo Bioworks worth $28 as of Q3 2026.
- Ginkgo Bioworks was a new Blue Trust position in Q3 2026.
- Ginkgo Bioworks made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2490 holding.
- Blue Trust first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 6 quarters since.
- Blue Trust's Ginkgo Bioworks position peaked at $7K in Q4 2023.
- 132 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.